Submit or Track your Manuscript LOG-IN

Attenuated Rift Valley Fever Virus (NMP18) Chemically for Vaccine Development

Attenuated Rift Valley Fever Virus (NMP18) Chemically for Vaccine Development

M.S. Wassel1; Elham A. El-Ebiary1; Soliman, Y.A.l and El-Sayed, M.M.2

1 Central Laboratory for Evaluation of Veterinary Biologics, Abbasia, Cairo.
2 veterinary Medicine and Diseases Department, Faculty of Veterinary Medicine. Cairo University.

ABSTRACT

Serial treatment of RVF virus ZH501 with nitrous acid and 5-flourouracil has been employed to derive an attenuated strain of Rift valley Fever virus (NMP18) for use as alive virus vaccine besides studying its safety, potency, and the duration of immunity in pregnant and non-pregnant sheep and cattle as well as remaining its antigenic and immunogenic power in animals using its protein analysis and Western blotting.

To share on other social networks, click on any share button. What are these?

Journal of Virological Sciences

July

Vol. 3, Iss. 1

Featuring

Click here for more

Subscribe Today

Receive free updates on new articles, opportunities and benefits


Subscribe Unsubscribe